Eswatini vs Namibia: Number of people requiring preventive treatment for schistosomiasis
Eswatini
411,702 people
in 2024
Namibia
196,714 people
in 2024
Eswatini rank
40th
Namibia rank
43rd
Number of people requiring preventive treatment for schistosomiasis over time
- Eswatini
- Namibia
How they compare
Eswatini currently reports 411,702 people against 196,714 people in Namibia, a difference of 214,988 people.
That makes Eswatini's figure about 2.1 times Namibia's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Namibia ahead.
Eswatini ranks 40th and Namibia ranks 43rd of 52 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and Namibia in 1.
Head to head by decade
| Decade | Eswatini | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 304,182 people | 324,831 people | 20,650 people | Namibia |
| 2020s | 340,355 people | 192,808 people | 147,547 people | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of people requiring preventive treatment for schistosomiasis, Eswatini or Namibia?
- Eswatini, at 411,702 people against 196,714 people in Namibia as of 2024.
- What is the difference in number of people requiring preventive treatment for schistosomiasis between Eswatini and Namibia?
- 214,988 people, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Namibia?
- 15 years are reported by both, from 2010 to 2024.
- How do Eswatini and Namibia rank globally for number of people requiring preventive treatment for schistosomiasis?
- Eswatini ranks 40th and Namibia ranks 43rd of 52 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Number of people requiring preventive treatment for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Population requiring preventive chemotherapy for schistosomiasis.